Qualigen Therapeutics Inc. (AIXC)
Market Open
15 Jun, 14:44
NASDAQ (CM) NASDAQ (CM) Primary $
1. 43
+0.04
+2.7482%
$
5.99M Market Cap
- P/E Ratio
- Div Yield
8,459 Volume
-2.7 Eps
$ 1.39
Previous Close Investors:
Want to track AIXC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
AIXC Earnings Reports FAQ
What is the earnings per share (EPS) for AIXC?
The current EPS is -2.7.
What is the company's earnings growth rate?
Qualigen Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Qualigen Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Qualigen Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for AIXC at this time, as Qualigen Therapeutics Inc has no recent EPS data to calculate it.
